Clinical trial

First in Human Study for Safety and Tolerability of AL003.

NCT03822208

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-03-29

PhasePHASE1

Study timeline

Study start (actual)2019-03-29Date precision: day

Registry last updated2021-09-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Healthyunresolved

Alzheimer Diseaseunresolved

Interventions

AL003BIOLOGICAL

Saline SolutionOTHER

Sponsors & collaborators

Alector Inc.lead sponsor

Mapped research locations

New YorkNew York, United States1 OrlandoFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03822208 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.